|
?:authorAffiliation
|
-
[\'ASRT, Inc, Atlanta, Georgia, USA.\', \'Mycotic Disease Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'California Emerging Infections Program, Oakland, California, USA.\', \'Colorado Department of Public Health and Environment, Denver, Colorado, USA.\', \'Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA.\', \'Atlanta VA Medical Center, Atlanta, Georgia, USA.\', \'Foundation for Atlanta Veterans Education and Research, Atlanta, Georgia, USA.\', \'Georgia Emerging Infections Program, Atlanta, Georgia, USA.\', \'Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.\', \'Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.\', \'New Mexico Emerging Infections Program, University of New Mexico, Albuquerque, New Mexico,USA.\', \'University of Rochester School of Medicine, Rochester, New York, USA.\', \'Vanderbilt University School of Medicine, Nashville, Tennessee, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}